DaVita Inc. Reels From Cyberattack — Can It Restore Treatment Volumes & Revenue Growth?

DaVita Inc., a leading provider of kidney dialysis services, reported its second-quarter 2025 earnings. The company highlighted a relatively stable financial performance but continues to face challenges in treatment volumes and missed treatments, partially attributable to a cyber incident earlier in the year. On the positive side, DaVita demonstrated an ability to manage costs effectively, which helped maintain its guidance for adjusted operating income and earnings per share for the full year. During the second quarter, adjusted operating income was $551 million, with adjusted earnings per share reaching $2.95. Cost management, particularly in labor productivity within U.S. dialysis operations, played a crucial role in offsetting revenue pressures. Additionally, DaVita benefited from cost savings realized in patient care costs, resulting in a 5% to 6% improvement year-over-year.